ROSEN, LEADING INVESTOR COUNSEL, Encourages TransMedics Group, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action Commenced by the Firm – TMDX

Core Viewpoint - Rosen Law Firm is reminding investors who purchased TransMedics Group, Inc. securities between February 28, 2023, and January 10, 2025, of the April 15, 2025, deadline to become lead plaintiffs in a class action lawsuit [1] Group 1: Class Action Details - Investors who purchased TransMedics securities during the specified Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2] - A class action lawsuit has already been filed, and interested parties can join by contacting the law firm [3][6] - The lead plaintiff must file a motion with the Court by April 15, 2025, to represent other class members [3] Group 2: Law Firm Credentials - Rosen Law Firm emphasizes the importance of selecting qualified counsel with a successful track record in securities class actions [4] - The firm has achieved significant settlements, including the largest securities class action settlement against a Chinese company at the time and has been ranked highly for its performance in this area [4] - In 2019, the firm secured over $438 million for investors, showcasing its capability in recovering funds for clients [4] Group 3: Case Allegations - The lawsuit alleges that TransMedics made materially false and misleading statements, including the use of kickbacks and fraudulent practices to generate revenue [5] - It is claimed that TransMedics engaged in unsafe practices and lacked proper safety oversight, which increased regulatory scrutiny [5] - The misleading statements about the company's business and operations led to investor damages when the true information became public [5]